Efsd and Jdrf and Lilly European Programme in Type 1 Diabetes Research 2016

Esta convocatoria pretende promover proyectos de investigación europeos y países asociados para aumentar el conocimiento de la diabetes tipo 1 mediante investigación clínica y básica, acelerar la aplicación de los avances científicos en la comprensión de la etiología, patogenia, tratamiento y prevención de la diabetes tipo 1 y sus complicaciones, fomentar la investigación translacional y aumentar la conciencia pública de la magnitud de esta enfermedad.
Este año se subvencionarán preferentemente proyectos dentro de las siguientes temáticas:
Research with potential to increase understanding of the natural history, pathogenesis, heterogeneity and/or aetiology of human type 1 diabetes;
Pancreatic beta cell biology and potential human beta cell regenerative approaches.
Pathophysiology of type 1 diabetes autoimmunity with a focus on potential therapeutic targets and testing of autoantigen-specific immunoregulation of type 1 diabetes.
Development and/or testing of therapies that slow or stop the progression of type 1 diabetes before symptomatic disease or that preserve beta cell function in new onsettype 1 diabetes.
Biomaterials and novel devices for implantable, encapsulated beta cell replacement.
Automated closed loop artificial pancreas systems and/or its components.
Novel or repurposed therapies to improve glycaemic and overall metabolic control in type 1 diabetes.
Glucose-responsive insulin.
Therapies that prevent progression of diabetic kidney or eye disease in type 1 diabetes;
Discovery of diagnostic, prognostic or predictive biomarkers for all stages of type 1 diabetes to enable “smart” clinical trials.

Mas información